Probing the missing mature β-cell proteomic landscape in differentiating patient iPSC-derived cells

Abstract MODY1 is a maturity-onset monogenic diabetes, caused by heterozygous mutations of the HNF4A gene. To date the cellular and molecular mechanisms leading to disease onset remain largely unknown. In this study, we demonstrate that insulin-positive cells can be generated in vitro from human ind...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Heidrun Vethe, Yngvild Bjørlykke, Luiza M. Ghila, Joao A. Paulo, Hanne Scholz, Steven P. Gygi, Simona Chera, Helge Ræder
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/91757cd6189546db8502a9227b934527
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:91757cd6189546db8502a9227b934527
record_format dspace
spelling oai:doaj.org-article:91757cd6189546db8502a9227b9345272021-12-02T11:40:50ZProbing the missing mature β-cell proteomic landscape in differentiating patient iPSC-derived cells10.1038/s41598-017-04979-w2045-2322https://doaj.org/article/91757cd6189546db8502a9227b9345272017-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-04979-whttps://doaj.org/toc/2045-2322Abstract MODY1 is a maturity-onset monogenic diabetes, caused by heterozygous mutations of the HNF4A gene. To date the cellular and molecular mechanisms leading to disease onset remain largely unknown. In this study, we demonstrate that insulin-positive cells can be generated in vitro from human induced pluripotent stem cells (hiPSCs) derived from patients carrying a non-sense HNF4A mutation, proving for the first time, that a human HNF4A mutation is neither blocking the expression of the insulin genes nor the development of insulin-producing cells in vitro. However, regardless of the mutation or diabetes status, these insulin-producing cells are immature, a common downfall off most current β-cell differentiation protocols. To further address the immature state of the cells, in vitro differentiated cells and adult human islets were compared by global proteomic analysis. We report the predicted upstream regulators and signalling pathways characterizing the proteome landscape of each entity. Subsequently, we focused on the molecular components absent or misregulated in the in vitro differentiated cells, to probe the components involved in the deficient in vitro maturation towards fully functional β-cells. This analysis identified the modulation of key developmental signalling pathways representing potential targets for improving the efficiency of the current differentiation protocols.Heidrun VetheYngvild BjørlykkeLuiza M. GhilaJoao A. PauloHanne ScholzSteven P. GygiSimona CheraHelge RæderNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-14 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Heidrun Vethe
Yngvild Bjørlykke
Luiza M. Ghila
Joao A. Paulo
Hanne Scholz
Steven P. Gygi
Simona Chera
Helge Ræder
Probing the missing mature β-cell proteomic landscape in differentiating patient iPSC-derived cells
description Abstract MODY1 is a maturity-onset monogenic diabetes, caused by heterozygous mutations of the HNF4A gene. To date the cellular and molecular mechanisms leading to disease onset remain largely unknown. In this study, we demonstrate that insulin-positive cells can be generated in vitro from human induced pluripotent stem cells (hiPSCs) derived from patients carrying a non-sense HNF4A mutation, proving for the first time, that a human HNF4A mutation is neither blocking the expression of the insulin genes nor the development of insulin-producing cells in vitro. However, regardless of the mutation or diabetes status, these insulin-producing cells are immature, a common downfall off most current β-cell differentiation protocols. To further address the immature state of the cells, in vitro differentiated cells and adult human islets were compared by global proteomic analysis. We report the predicted upstream regulators and signalling pathways characterizing the proteome landscape of each entity. Subsequently, we focused on the molecular components absent or misregulated in the in vitro differentiated cells, to probe the components involved in the deficient in vitro maturation towards fully functional β-cells. This analysis identified the modulation of key developmental signalling pathways representing potential targets for improving the efficiency of the current differentiation protocols.
format article
author Heidrun Vethe
Yngvild Bjørlykke
Luiza M. Ghila
Joao A. Paulo
Hanne Scholz
Steven P. Gygi
Simona Chera
Helge Ræder
author_facet Heidrun Vethe
Yngvild Bjørlykke
Luiza M. Ghila
Joao A. Paulo
Hanne Scholz
Steven P. Gygi
Simona Chera
Helge Ræder
author_sort Heidrun Vethe
title Probing the missing mature β-cell proteomic landscape in differentiating patient iPSC-derived cells
title_short Probing the missing mature β-cell proteomic landscape in differentiating patient iPSC-derived cells
title_full Probing the missing mature β-cell proteomic landscape in differentiating patient iPSC-derived cells
title_fullStr Probing the missing mature β-cell proteomic landscape in differentiating patient iPSC-derived cells
title_full_unstemmed Probing the missing mature β-cell proteomic landscape in differentiating patient iPSC-derived cells
title_sort probing the missing mature β-cell proteomic landscape in differentiating patient ipsc-derived cells
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/91757cd6189546db8502a9227b934527
work_keys_str_mv AT heidrunvethe probingthemissingmaturebcellproteomiclandscapeindifferentiatingpatientipscderivedcells
AT yngvildbjørlykke probingthemissingmaturebcellproteomiclandscapeindifferentiatingpatientipscderivedcells
AT luizamghila probingthemissingmaturebcellproteomiclandscapeindifferentiatingpatientipscderivedcells
AT joaoapaulo probingthemissingmaturebcellproteomiclandscapeindifferentiatingpatientipscderivedcells
AT hannescholz probingthemissingmaturebcellproteomiclandscapeindifferentiatingpatientipscderivedcells
AT stevenpgygi probingthemissingmaturebcellproteomiclandscapeindifferentiatingpatientipscderivedcells
AT simonachera probingthemissingmaturebcellproteomiclandscapeindifferentiatingpatientipscderivedcells
AT helgeræder probingthemissingmaturebcellproteomiclandscapeindifferentiatingpatientipscderivedcells
_version_ 1718395530072031232